Detalhe da pesquisa
1.
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study.
Ann Hematol
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443660
2.
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study.
J Med Internet Res
; 25: e38619, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790852
3.
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.
N Engl J Med
; 380(23): 2225-2236, 2019 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31166681
4.
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma.
Blood
; 136(23): 2628-2637, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785666
5.
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 21(9): 1188-1200, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888452
6.
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Br J Haematol
; 189(1): 84-96, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31702836
7.
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
N Engl J Med
; 377(13): 1250-1260, 2017 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28953447
8.
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.
Blood
; 131(2): 174-181, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061568
9.
Prospective study of a web-mediated management of febrile neutropenia related to chemotherapy (Bioconnect).
Support Care Cancer
; 27(6): 2189-2194, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30306327
10.
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study.
Br J Haematol
; 181(3): 341-349, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611187
11.
Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer.
Support Care Cancer
; 26(1): 81-89, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756472
12.
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
Br J Haematol
; 179(3): 439-448, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28770576
13.
Oral CHOP-like chemotherapy in 60-80 years-old patients with diffuse large B-cell lymphoma.
Br J Haematol
; 186(6): e175-e178, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309541
14.
Anaemia in hospitalized cancer patients: a retrospective study of two cohorts before and after the guideline update.
Oncol Res Treat
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38714181
15.
Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life.
Am J Hematol
; 93(10): E329-E331, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30019460
16.
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial.
JMIR Res Protoc
; 11(11): e40969, 2022 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427234
17.
Extranodal classical Hodgkin lymphoma involving the spinal cord: case report and review of the literature.
CNS Oncol
; 11(3): CNS88, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35694977
18.
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs.
Blood Adv
; 6(17): 5171-5183, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802458
19.
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study.
Blood Adv
; 5(19): 3862-3872, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461634